ACTC 2014 CONFIRMED SPEAKERS

  • Sofia AgelakiM.D.,PHD, Ass. Professor, Medical School, University of Crete, Greece
  • Julio Aguirre-Ghiso, Professor, Mount Sinai School of Medicine, New York, USA.
  • Catherine Alix-Panabières, PhD, Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB , Hôpital Saint-Eloi - CHRU Montpellier, France.
  • Michael F. Clarke, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, USA.
  • Richard J. Cote, M.D., FRCPath, Professor and Chair, Department of Pathology, University of Miami Miller School of Medicine, Miami, USA.
  • Massimo Cristofanilli, MD, FACP, Appointed Director of the Jefferson Breast Care Center, Kimmel Cancer Center, Philadelphia, PA, USA
  • Caroline Dive, PhD, Senior Group Leader at the Paterson Institute for Cancer Research and Professor of Pharmacology at The University of Manchester, UK.
  • Tanja Fehm, Professor, Department of Gynaecology, University of Dusseldorf, Germany.
  • Dave Hoon, M.Sc., Ph.D, Director, Department of Molecular Oncology, John Wayne cancer Institute, Santa Monica, CA, USA.
  • Michail Ignatiadis, MD, PhD, Jules Bordet Institute, Brussels, Belgium.
  • Stefanie S. Jeffrey, MD, Professor of Surgery, Stanford, USA.
  • Yibin Kang, PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University, Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
  • Sabine Kasimir-Bauer, PhD, Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany.
  • Gary J. KelloffM.D., Special Advisor, DCTD, NCI, NIH, and Chair Cancer Biomarker Consortium, FNIH,USA
  • Christoph A. Klein, MD, Professor, Head of the Chair, Division of Oncogenomics, Department of Pathology, University of Regensburg, Regensburg, Germany.
  • Hasan Korkaya, D.V.M., Ph.D., Assistant Professor at Georgia Regents University Cancer Center, Georgia, USA.
  • Peter Kuhn, PhD, Professor, University of Southern California (USC), Los Angeles, USA
  • Evi Lianidou, PhD, Professor, University of Athens, Greece.
  • Masaki Mori, MD, PhD, FACS, Chairman Professor of Surgery, Graduate School of Medicine, Osaka University, Japan.
  • Bjorn Naume, Professor, Oslo University Hospital, Division of Surgery and Cancer Medicine, Department of Oncology, Oslo, Norway.
  • Klaus Pantel, MD, PhD, Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany.
  • Jean-Yves Pierga, MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France.
  • Anieta Sieuwerts, MD. PhD, Dept of Translational Cancer Genomics and Proteomics, Erasmus Medical Center, Rotterdam, Netherlands.
  • Leon Terstappen, PhD, Professor, Faculty of Science and Technology, MIRA Research Institute, Department of Medical Cell BioPhysics, University of Twente, the Netherlands.
  • Jean Paul Thiery, Professor, Head Of Department, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, SINGAPORE.
  • Andreas Trumpp, Professor and Head of the Department for Cell Biology, German Cancer Research Center (DKFZ) Heidelberg, Germany.
  • Danny R. Welch, PhD, Professor and Chair, Adjunct faculty of Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, USA.
  • Max Wicha, M.D., Professor, Department of Internal Medicine, Director, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.